This compound is a morpholine-based pharmaceutical intermediate containing multiple fluorine atoms and a chiral center. It is primarily used in the synthesis of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 171482-05-6
(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine 4-methylbenzenesulfonate
pharmaceutical intermediate
(2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl) morpholine
research compound
2'-O-Propargyl g(iBu)-3'-phosphoramidite
pharmaceutical intermediate
2'-propargyl U amidite
pharmaceutical intermediate
Chloropretadalafil
pharmaceutical intermediate
8-Bromo-2'-benzamido-2'-deoxy-Adenosine
pharmaceutical intermediate
(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine;hydrochloride
DWCCMKXSGCKMJF-YNXGUESPSA-N
C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](NCCO2)C3=CC=C(C=C3)F.Cl